Assembly Biosciences is experiencing a dramatic stock rally following the release of groundbreaking clinical trial results.

The investment community is buzzing with renewed optimism for Robinhood Markets following the fintech platform's impressive third-quarter earnings release. M ...

Understanding the properties of different materials is an important step in material design. X-ray absorption spectroscopy ...

Understanding, organizing, and validating data directly affects the accuracy of stories. New tools make cleaning accessible ...

Bay's stock price target has seen a modest uptick, with consensus analyst estimates moving from $91.55 to $94.93. This subtle shift reflects a mix of analyst optimism and healthy skepticism, fueled by ...

BioCryst Pharmaceuticals' stock narrative shifted recently as analysts adjusted their fair value estimate from $20.27 to $19.73 per share. This modest decrease follows the company’s acquisition of ...

Intellia Therapeutics (NASDAQ: NTLA) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of ...

The furious push by AI hyperscalers to build out data centers will need about $1.5 trillion of investment-grade bonds over ...

In the assessment of 12-month price targets, analysts unveil insights for CoreWeave, presenting an average target of $151.73, ...

In this excerpt from the new book 'Speak Data,' the Wharton professor and best-selling author shares his thoughts on how we ...

BRT Apartments Corp. offers 6.9% yield and 67% payout ratio, but faces headwinds from Sun Belt oversupply & higher ...

Get key insights from Lument Finance Trust's Q3 2025 earnings call—discover strategies, risk management, and new growth opportunities.